Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

A woman developed male characteristics after using unregulated hormone therapy.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Ovarian hyperthecosis can cause polycythemia, and surgery can normalize symptoms.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

A boy with early puberty and laughing seizures was treated, stopping seizures and slowing puberty.